RxLightning

Overview
News
Hospital-at-Home?
Product stageSegments
Minimum Viable Product
?
Medication Management
?

RxLightning is a medical technology company founded in 2020 that has developed a comprehensive digital platform to streamline the specialty medication enrollment process. The company's solution digitizes, automates, and simplifies the traditionally complex and manual process of getting patients started on specialty medications. RxLightning's platform connects prescribers, specialty pharmacies, manufacturers, hubs, payers and foundations in one place, allowing healthcare providers to complete patient enrollment for over 1,200 specialty medications across all therapeutic areas. This significantly reduces administrative burdens and accelerates patient access to critical treatments.

The company's MedAccess Ecosystem provides full visibility into each step of the patient onboarding journey for all stakeholders. By removing paper forms, phone calls, and faxes from the enrollment process, RxLightning has been able to reduce wait times for specialty medication approvals from weeks or months down to just days in many cases. For example, one oncology clinic reported that patient enrollment times were reduced from 12-15 days to just 2-3 days using RxLightning's platform. The company offers its solution at no cost to healthcare providers. As of June 2023, RxLightning had raised USD 20.5 million in funding to support its growth and further development of its technology.

Key customers and partnerships

RxLightning has established partnerships with several major healthcare organizations. In October 2022, the company partnered with American Oncology Network (AON) to provide AON's community oncology practices with digital financial assistance enrollment for specialty medications. Early results showed 79% of patients were enrolled in less than one day using RxLightning's platform, compared to over a week previously.

In February 2023, RxLightning announced a partnership with Yale New Haven Health to streamline specialty medication access for patients within the Yale New Haven Health system. The company has also worked with large oncology clinics and health systems across the country to implement its solution.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
New Albany IN USA
Founded year:
2020
Employees:
11-50
IPO status:
Private
Total funding:
USD 20.5 mn
Last Funding:
USD 17.5 mn (Series A; Jun 2023)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.